The negative consequences of structural racism on mental health, and opportunities for change, are the focus of a special theme issue of the American Journal of Psychiatry (AJP), released to coincide with the American Psychiatric Association (APA) Annual Meeting. The hope is this special issue will “motivate clinicians, educators, and researchers to take actions that … Read more
SAN DIEGO — Treating people with alcoholic hepatitis for alcohol abuse may reduce their risk of hospital readmission, researchers reported. In a retrospective analysis of nationwide data, 7.83% of those patients who received psychotherapy, counseling, or drug treatment for alcohol abuse were readmitted within 30 days, versus 11.67% of those who did not receive these … Read more
What is the role of cannabinoids as an intoxicant and in medical applications today? This was the question addressed by Dieter Braus, MD, psychiatrist and neurologist at Vitos Clinic Rheingau in Eltville, Germany, at the DGIM Congress 2022. Dampening the Dopamine System Regardless of the type of substance-dependent addiction — whether alcohol, opiates, nicotine, or … Read more
Disulfiram, a US Food and Drug Admiistration (FDA)–approved medication for the treatment of chronic alcohol dependence, shows promise as a potential anxiolytic, early research suggests. Japanese researchers, headed by Akiyoshi Saitoh, PhD, professor in the Department of Pharmacy, Tokyo University of Science, compared the reactions of mice that received a classic anxiolytic agent (diazepam) to … Read more
Jon E. Grant, JD, MD, MPH Trichotillomania is a chronic psychiatric disorder that causes people to repeatedly pull out their own hair. Not only does it result in alopecia with no other underlying causes but it can have significant psychosocial ramifications and rare, but serious, complications. Though reported prevalence rates of up to approximately 2%, … Read more
